205 related articles for article (PubMed ID: 23315732)
1. Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus.
MacPhee RA; Miller WL; Gloor GB; McCormick JK; Hammond JA; Burton JP; Reid G
Appl Environ Microbiol; 2013 Mar; 79(6):1835-42. PubMed ID: 23315732
[TBL] [Abstract][Full Text] [Related]
2. Vaginal community state types (CSTs) alter environmental cues and production of the
Maduta CS; McCormick JK; Dufresne K
J Bacteriol; 2024 Mar; 206(3):e0044723. PubMed ID: 38334326
[TBL] [Abstract][Full Text] [Related]
3. Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.
Parsonnet J; Hansmann MA; Seymour JL; Delaney ML; Dubois AM; Modern PA; Jones MB; Wild JE; Onderdonk AB
BMC Infect Dis; 2010 Aug; 10():249. PubMed ID: 20731864
[TBL] [Abstract][Full Text] [Related]
4. Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production
Nonfoux L; Chiaruzzi M; Badiou C; Baude J; Tristan A; Thioulouse J; Muller D; Prigent-Combaret C; Lina G
Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29678918
[TBL] [Abstract][Full Text] [Related]
5. The effect of vaginal microbial communities on colonization by Staphylococcus aureus with the gene for toxic shock syndrome toxin 1 (TSST-1): a case-control study.
Pierson JD; Hansmann MA; Davis CC; Forney LJ
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29762733
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1) production and Lactobacillus species growth in a defined medium simulating vaginal secretions.
Stingley RL; Liu H; Mullis LB; Elkins CA; Hart ME
J Microbiol Methods; 2014 Nov; 106():57-66. PubMed ID: 25135489
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Toxic Shock Syndrome-Associated
Schlievert PM; Gaitán AV; Kilgore SH; Roe AL; Maukonen J; Lehtoranta L; Leung DYM; Marsman DS
Microbiol Spectr; 2023 Aug; 11(4):e0173523. PubMed ID: 37404182
[TBL] [Abstract][Full Text] [Related]
8. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
9. Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay.
Rosten PM; Bartlett KH; Chow AW
J Clin Microbiol; 1987 Feb; 25(2):327-32. PubMed ID: 3818927
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women.
Parsonnet J; Goering RV; Hansmann MA; Jones MB; Ohtagaki K; Davis CC; Totsuka K
J Clin Microbiol; 2008 Aug; 46(8):2731-8. PubMed ID: 18550735
[TBL] [Abstract][Full Text] [Related]
11. A toroid model for in vitro investigations of toxic shock syndrome toxin-1 production.
Flood JA; Tripp TJ; Davis CC; Hill DR; Schlievert PM
J Microbiol Methods; 2004 May; 57(2):283-8. PubMed ID: 15063069
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
[TBL] [Abstract][Full Text] [Related]
13. Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus.
Lee JC; Liu MJ; Parsonnet J; Arbeit RD
J Clin Microbiol; 1990 Dec; 28(12):2612-5. PubMed ID: 2279990
[TBL] [Abstract][Full Text] [Related]
14. Toxic shock syndrome toxin-1 (TSST-1) production and phage susceptibility of Staphylococcus aureus strains from human vaginas and anterior nares in Trinidad.
Adesiyun AA; Singh D; Gunness RI
Zentralbl Bakteriol; 1994 Jan; 280(3):371-81. PubMed ID: 8167431
[TBL] [Abstract][Full Text] [Related]
15. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
Schlievert PM
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
[TBL] [Abstract][Full Text] [Related]
16. Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
McNamara PJ; Syverson RE; Milligan-Myhre K; Frolova O; Schroeder S; Kidder J; Hoang T; Proctor RA
Antimicrob Agents Chemother; 2009 May; 53(5):1898-906. PubMed ID: 19223628
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.
Parsonnet J; Hansmann MA; Delaney ML; Modern PA; Dubois AM; Wieland-Alter W; Wissemann KW; Wild JE; Jones MB; Seymour JL; Onderdonk AB
J Clin Microbiol; 2005 Sep; 43(9):4628-34. PubMed ID: 16145118
[TBL] [Abstract][Full Text] [Related]
18. [Methicillin resistance, production of toxic shock syndrome toxin-1 and types of enterotoxin, protease and coagulase at vaginal isolates of Staphylococcus aureus].
Arai K; Mitsuta T; Fujita S; Yokota S
Kansenshogaku Zasshi; 1993 Oct; 67(10):1005-10. PubMed ID: 8254212
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines.
Schlievert PM; Cahill MP; Hostager BS; Brosnahan AJ; Klingelhutz AJ; Gourronc FA; Bishop GA; Leung DYM
mBio; 2019 Mar; 10(2):. PubMed ID: 30890614
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
Park JY; Kim JS; Woo H
Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
